Starting on:
Oct 20, 2022
Ending on:
Oct 20, 2022
Moderator(s):
Venue:
Max Credits:
3 Points
Provider:
Kenya Society of Hematology & Oncology
Claim Points
Oct 20, 2022
Ending on:
Oct 20, 2022
Moderator(s):
Max Credits:
3 Points
Provider:
Kenya Society of Hematology & Oncology
Claim Points
Optimizing Treatment Outcomes for HR+ and HR2 -VE Metastatic Breast Cancer
Starting on:
Oct 20, 2022 7:00 PM
Oct 20, 2022 7:00 PM
Ending on:
Oct 20, 2022 8:30 PM
Oct 20, 2022 8:30 PM
Venue:
Description
Optimizing Treatment Outcomes for HR+ and HR2 -VE Metastatic Breast Cancer
Objectives
1. Overview of the Guidelines and New Treatments Available
2. Local Perspectives on Management & Treatment Outcomes of HR+/HER2- Advanced Disease
Presenters
-
Dr.
Siwillis Elizabeth Mithe
Consultant Clinical Radiation Oncologist
Nakuru County Teaching and Referral Hospital -
Prof.
Olivia Pagani
European School of Oncology
University of Geneva & Lugano -
Dr.
Amina Kidee
Medical Oncologist
Aga Khan University Hospital, Mombasa